3 deals
Director, AdvanCell
Bali Muralidhar
Roles
| Role | Organisation | Sources |
|---|---|---|
| Director | AdvanCell | Startup Daily, Brandon Capital |
Coverage
Stories naming Bali Muralidhar. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Series C
US$112m
AdvanCell Successfully Completes an Oversubscribed US$112M Series C Financing
Sydney cancer-therapy developer AdvanCell has completed a US$112 million Series C that was oversubscribed, co-led by four investors, with Brandon Capital among new backers; three investor representatives join the board.